Newest guidelines for managing risk of sepsis show clinical impactHigh physician compliance, decreased resource utilization seen in Toronto hospital Exposure to virulent E. coli strain sparks renal, cardiac diseaseLong-term followup of Walkerton victims reveals lasting impact on health Up your nose . . . with a flu vaccine U.S. group suggests intranasal influenza agent is highly effective in kids WHO declares H1N1 pandemic over Not just a devoted do-gooder Florence Nightingale was a radical who revolutionized hospital care Treating HIV cuts community-wide infections B.C. study suggests expansion of antiretroviral therapy curtails new diagnoses Stick with cryotherapy for treatment of warts Poor performance of off-label immune stimulant in comparative trial leaves dermatologists cold Guide to OTC Health Management: Vulvovaginitis Asking the right questions, providing the right answers Shingles: Prevention and management of herpes zoster Drug News: Actemra, BuTrans, Onsolis, Victoza Actemra: first IL-6 receptor inhibitor for RA; BuTrans: first once-weekly transdermal opioid; Onsolis: opioid buccal film for breakthrough cancer pain; Victoza: first GLP-1 analogue for type 2 diabetes First Previous 612 613 614 615 616 Next Last
